Healthcare & Pharmaceuticals SEC Filings — 2025

Pharmaceuticals, biotech, medical devices, and health services companies In 2025, healthcare & pharmaceuticals companies filed regulatory disclosures with the SEC including annual reports, quarterly updates, insider transactions, and material event notifications.

500 total filings across 9 form types.

Filing Types in 2025

Latest Filings (30)

Frequently Asked Questions

How many SEC filings did healthcare & pharmaceuticals companies make in 2025?

Healthcare & Pharmaceuticals companies filed 500 SEC filings in 2025. The most common types were 8-K (320), 6-K (114), DEF 14A (17).

What types of SEC filings do healthcare & pharmaceuticals companies file?

Healthcare & Pharmaceuticals companies file 10-K annual reports, 10-Q quarterly reports, 8-K current reports, Form 4 insider disclosures, 13F-HR institutional holdings, S-1 IPO registrations, and more.

How can I track healthcare & pharmaceuticals filing trends in 2025?

Read The Filing provides AI-powered summaries, risk assessments, and sentiment analysis for every healthcare & pharmaceuticals SEC filing. You can browse by form type, compare companies, and track monthly patterns.

View on Read The Filing